<DOC>
	<DOC>NCT02827071</DOC>
	<brief_summary>The purpose of this study is to evaluate this AngioScan angiography software on patients with various retinal vascular disorders. The advanced OCT instrument is an FDA approved clinically used camera, but the AngioScan angiography software is not FDA approved. Investigators would like to know if this imaging device and software can improve the quality of images and visualization of imaged tissues and whether they are useful in the diagnosis and treatment of eye diseases. Images collected in this study may be compared to other images collected as part of standard of care on the same patient (OCT, FA, AF, Fundus).</brief_summary>
	<brief_title>Ocular Imaging Study Using Advanced OCT</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Vascular Diseases</mesh_term>
	<criteria>â€¢ Any patient with abnormal retinal findings as determined by investigators. Those suffering from head, neck or other injury which makes them unable to position themselves in head restraint for imaging. Participants who are unable to maintain retinal fixation on a specified target. Participants unable to achieve sufficient pupil dilation and alignment stability for imaging to take place. Patients with media opacity which preclude high quality imaging.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>115 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>